Cholesterol, a Modulator of Membrane-associated Aβ-fibrillogenesis

Pharmacopsychiatry

Volumn 36, Issue SUPPL. 2, 2003, Pages

  McLaurin, J ^a   Darabie, A A ^a   Morrison, M R ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; CHOLESTEROL; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANISOTROPY; ATOMIC FORCE MICROSCOPY; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE FLUIDITY; CELL SURFACE; CONFERENCE PAPER; CORRELATION ANALYSIS; ELECTRON MICROSCOPY; FIBER; FLUORESCENCE ANALYSIS; FLUOROMETRY; HUMAN; HYDROPHOBICITY; HYPOTHESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; SENILE PLAQUE; SPECIES;

AMYLOID BETA-PROTEIN; ANIMALS; BETA-CYCLODEXTRINS; BRAIN; BRAIN CHEMISTRY; CHOLESTEROL; CYCLODEXTRINS; DIHYDROPYRIDINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIPID BILAYERS; MEMBRANE FLUIDITY; MICROSCOPY, ATOMIC FORCE; NEUROFIBRILLARY TANGLES; PEPTIDE FRAGMENTS; SPECTROMETRY, FLUORESCENCE; TIME FACTORS;

EID: 0242383360     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. Avdulov NA, Chochina SV, Igbavboa U, O'Hare EO, Schroeder F, Cleary JP, Wood WG. Lipid binding to amyloid beta-peptide aggregates: preferential binding of cholesterol as compared with phosphatidylcholine and fatty acids. J Neurochemistry 1997; 69: 1746-1752
2. Bayerl TM, Bloom M. Physical properties of single phospholipid bilayers adsorbed to micro glass beads. A new vesicular model system studied by 2H-nuclear magnetic resonance. Biophys J 1990; 58: 357-362
3. Bodovitz S, Klein WL. Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. J Biol Chem 1996; 271: 4436-4440
4. Brian AA, McConnell HM. Allogeneic stimulation of cytotoxic T cells by supported planar membranes. Proc Natl Acad Sci USA 1984; 81: 6159-6163
5. DePlanque MRR, Greathouse DV, Koeppe RE, Schafer H, Marsh D, Killian JA. Influence of lipid/peptide hydrophobic mismatch on the thickness of diacylphosphatidylcholine bilayers. A 2H NMR and ESR study using designed transmembrane α-helical peptides and gramicidin A. Biochemistry 1998; 37: 9333-9345
6. Galbete JL, Rodriguez-Martin T, Peressini E, Modena P, Bianchi R, Forloni G. Cholesterol decreases secretion of the secreted form of amyloid precursor protein by interfering with glycosylation in the protein secretory pathway. Biochem J 2000; 348: 307-313
7. Gimpl G, Burger K, Fahrenholz F. Cholesterol as modulator of receptor function. Biochemistry 1997; 36: 10959-10974
8. Groves JT, Ulman N, Boxer SG. Micropatterning fluid lipid bilayers on solid supports. Science 1997; 275: 651-653
9. Hertel C, Terzi E, Hauser N, Jakob-Rotne R, Seelig J, Kemp JA. Inhibition of the electrostatic interaction between beta-amyloid peptide and membranes prevents beta-amyloid-induced toxicity. Proc Natl Acad Sci 1997; 94: 9412-9416
10. Howland DS, Trusko SP, Savage MJ, Reaume AG, Lang DM, Hirsch JD, et al. Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol. J Biol Chem 1998; 273: 16576-16582
11. Janshoff A, Bong DT, Steinem C, Johnson JE, and Ghadiri MR. An animal virus-derived peptide switches membrane morphology: possible relevance to Nodaviral transfection processes. Biochemistry 1999; 38: 5328-5336
12. Kawahara M, Kuroda Y, Arispe N, Rojas E. Alzheimer's beta-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line. J Biol Chem 2000; 275: 14077-14083
13. Kilsdonk EPC, Yancey PG, Stoudt GW, Bangerter FW, Johnson WJ. Cellular cholesterol efflux mediated by cyclodextrins. J Biol Chem 1995; 270: 17250-17256
14. McLaurin J, Franklin T, Chakrabartty A, Fraser PE. Phosphatidylinositol and inositol involvement in Alzheimer amyloid-beta fibril growth and arrest. J Mol Biol 1998; 278: 183-194
15. McLaurin J, Franklin T, Fraser PE, Chakrabartty A. Structural transitions associated with the interaction of Alzheimer beta-amyloid peptides with gangliosides. J Biol Chem 1997; 273: 4506-4515
16. McLaurin J, Yang D, Yip CM, Fraser PE. Modulating Factors in Aβ Fibril Formation. J Struct Biol 2000; 130: 259-270
17. Mizuno T, Nakata M, Naiki H, Michikawa M, Wang R, Haass C, Yanagisawa K. Cholesterol-dependent generation of a seeding amyloid beta-protein in cell culture. J Biol Chem 1999; 274: 15110-15114
18. Mou J, Czaijkowsky DM, and Shao Z. Gramicidin A aggregation in supported gel state phosphatidylcholine bilayers. Biochemistry 1996; 35: 3222-3226
19. Pillot T, Drouet B, Queille S, Labeur C, Vandekerchkhove J, Rosseneu M et al. Beta-amyloid peptide interacts specifically with the carboxy-terminal domain of human apolipoprotein E: relevance to Alzheimer's disease. J Neurochem 1999; 73: 1626-1634
20. Racchi M, Baetta R, Salvietti N, Ianna P, Franceschini G, Paoletti R et al. Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. Biochem J 1997; 322: 893-898
21. Refolo LM, Pappolla MA, Malester B, LaFrancois J, Bryant-Thomas T, Wang R, et al. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Disease 2000; 7: 321-331
22. Roher AE, Kuo Y-M, Kokjohn KM, Emmerling MR, Gracon S. Amyloid and lipids in the pathology of Alzheimer disease. Amyloid: Int J Exp Clin Inves 1999; 6: 136-145
23. Salafsky J, Groves JT, Boxer SG. Architecture and function of membrane proteins in planar supported bilayers: a study with photosynthetic reaction centers. Biochemistry 1996; 35: 14773-14781
24. Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 1996; 2: 864-870
25. Selkoe DJ, Alzheimer's disease: genotypes, phenotypes, and treatments. Science 1997; 275: 630-631
26. Simons M, Keller P, DeStrooper B, Beyreuther K, Dotti CG, Simons K. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 1998; 95: 6460-6464
27. Sparks DL, Scheff SW, Hunsaker JC, Liu H, Landers T, Gross DR. Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol 1994; 126: 88-94
28. St. George-Hyslop P. Molecular Genetics of Alzheimer's Disease. Biol Psychiatry 2000; 47: 183-199
29. Terzi E, Holzemann G, Seelig J. Alzheimer beta-amyloid peptide 25-35: electrostatic interactions with phospholipid membranes. Biochemistry 1994; 33: 7434-441
30. Terzi E, Holzemann G, Seelig J. Self-association of beta-amyloid peptide (1-40) in solution and binding to lipid membranes. J Mol Biol 1995; 252: 633-642
31. Van Blitterswijk WJ, VanHoeven RP, Van der Meer BW. Lipid structural order parameters (reciprocal of fluidity) in biomembranes derived from steady-state fluorescence polarization measurements. Biochim Biophys Acta 1981; 644: 323-332
32. Webster S, Rogers J. Relative efficacies of amyloid beta peptide (A beta) binding proteins in A beta aggregation. J Neurosci Res 1996; 4: 58-66
33. Wood WG, Schroeder F, Avdulov NA, Chochina SV, Igbavboa U. Recent advances in brain cholesterol dynamics: transport, domains, and Alzheimer's disease. Lipids 1999; 34: 225-234
34. Yamaguchi H, Maat-Schieman MLC, Duinen SG, Prins FA, Neeskens P, Natte R, Roos RAC. Amyloid beta protein (Abeta) starts to deposit as plasma membrane-bound form in diffuse plaques of brains from hereditary cerebral hemorrhage with amyloidosis-Dutch type, Alzheimer disease and nondemented aged subjects. J Neuropathol Exp Neurol 2000; 59: 723-732
35. Yip CM, McLaurin J. Amyloid-β Peptide Assembly: A Critical Step in Fibrillogenesis and Membrane Disruption. Biophys J 2000; 80: 1359-1371